Mr. Morfitt is a member of Frazier’s Growth Buyout team. He is focused on developing new investment opportunities and helping existing portfolio companies grow.
Mr. Morfitt, a General Partner, joined Frazier Healthcare Partners in 2003. He currently serves on the boards of Correct Care Solutions, Informed Medical Communications, Orthotic Holdings, and Leiter’s Compounding Pharmacy. He has also been involved in Frazier’s investments in Bravo Health (acquired by Health Spring), CHG Healthcare Services (acquired by J.W. Childs Associates), Pentec Health (acquired by NEP), Priority Solutions (acquired by Thermo Fisher Scientific), and TridentUSA Health Services (acquired by Formation Capital). In addition, he leads the Growth Buyout team’s debt capital markets activities.
Prior to joining Frazier, Mr. Morfitt worked at Summit Partners, a growth equity firm. While at Summit, he focused on identifying and evaluating investment opportunities in the healthcare, technology, and industrial sectors.
Mr. Morfitt is also on the board of the Health Care Private Equity Association.
Stanford University (B.S., Phi Beta Kappa, M.S.)